# RemSleep Holdings Inc.: Form 10-K for the period ended Dec 31, 2024

- Company: [RemSleep Holdings Inc.](/companies/rmsl.md) (CIK 1412126)
- Form: 10-K
- Filed: 2025-04-14
- Accepted by EDGAR: Apr 14, 2025, 16:37 ET
- Period: 2024-12-31
- Accession: 0001213900-25-031599
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1412126/000121390025031599/ea0236249-10k_remsleep.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1412126/000121390025031599/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $117.2k | us-gaap:Revenues |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $99.1k | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2024-01-01 to 2024-12-31 | $18.0k | us-gaap:GrossProfit |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $187.4k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −$793.5k | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $143.1k | us-gaap:InterestExpenseNonoperating |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | −$1.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 1,476,557,436 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −$683.1k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $124.7k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-12-31 | $463.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $491.7k | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $591.7k | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $255.0k | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $255.0k | us-gaap:Liabilities |
| Shareholders' equity | at 2024-12-31 | $336.7k | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1412126/000121390025031599/ea0236249-10k_remsleep.htm

Filed Apr 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-031599. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.